trending Market Intelligence /marketintelligence/en/news-insights/trending/9avdys2qx9zgwgrkty05eg2 content esgSubNav
In This List

Sesen Bio raises over $40M in common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Sesen Bio raises over $40M in common stock offering

Cambridge, Mass.-based Sesen Bio, formerly known as Eleven Biotherapeutics Inc., said it raised net proceeds of about $41.9 million via an offering of common shares.

The healthcare company sold 22,222,223 shares, plus a further 3,333,333 stock to the offering's underwriters, at $1.80 apiece.

The offering closed June 4, with Jefferies LLC and Canaccord Genuity LLC acting as representatives of underwriters.